Rv3323c Molybdenum cofactor biosynthesis protein MoaD / Molybdenum cofactor biosynthesis protein MoaE
|Symbol||Product||Feature Type||Start||End||Strand||Length||AA Length||is TF|
|Rv3323c||moaX||Molybdenum cofactor biosynthesis protein MoaD / Molybdenum cofactor biosynthesis protein MoaE||CDS||3709049||3709714||-||666||221||FALSE|
Rv3323c (Molybdenum cofactor biosynthesis protein MoaD / Molybdenum cofactor biosynthesis protein MoaE) is predicted to be co-regulated in modules bicluster_0204 with residual 0.42 and bicluster_0561 with residual 0.52.
These modules are enriched for following go terms: Mo-molybdopterin cofactor biosynthetic p..., Mo-molybdopterin cofactor metabolic proc..., molybdopterin cofactor biosynthetic proc..., molybdopterin cofactor metabolic process, prosthetic group metabolic process monovalent inorganic cation transport, metal ion transport, cation-transporting ATPase activity, metal ion transmembrane transporter acti..., monovalent inorganic cation transmembran..., ATPase activity, coupled to transmembran....
This gene is found to be for growth on cholesterol.
Mutant available?: Yes
|Product (LegacyBRC)||Product (RefSeq)|
|PROBABLE MOAD-MOAE FUSION PROTEIN MOAX||MOAD-MOAE fusion protein MOAX|
|BioCyc Gene Page||Cellular Overview Map|
reports the log2 abundance fold change of each TFI strain, relative to no induction, in absence or presence of drug, averaged across experimental replicates. Also reported are the accompanying z-scores and two-sided t-test p-values for each TFI strain under each condition. Please refer to Ma et al., 2020, Nature Microbiology for more information.